Buy Menlo Therapeutics Stock | MNLO Stock Price & Latest News | Public
MNLO

Menlo Therapeutics

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About MNLO

    Menlo Therapeutics is a clinical late-stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus (itch) associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis....Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.4
    -0.81
    -1.21
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.14

    Actual EPS
    Q4 2020

    Stats

    Market Cap$323,64M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$7.48
    1 Year Low$1.00
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app